Page last updated: 2024-11-07

triiodothyronine sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID122196
CHEMBL ID2074889
CHEBI ID35432
SCHEMBL ID2511358
MeSH IDM0113833

Synonyms (25)

Synonym
triiodothyronine sulfuric ester
triiodothyronine sulfate
31135-55-4
CHEBI:35432 ,
(2s)-2-amino-3-{3,5-diiodo-4-[3-iodo-4-(sulfooxy)phenoxy]phenyl}propanoic acid
(2s)-2-amino-3-[3,5-diiodo-4-(3-iodo-4-sulfooxyphenoxy)phenyl]propanoic acid
CHEMBL2074889
SCHEMBL2511358
DTXSID80185066
AKOS030254868
3,5,3'-triiodo-l-thyronine 4'-o-sulfate
o-(4-hydroxy-3-iodophenyl-4-o-sulphate)-3,5-diiodo-l-tyrosine
o-(4-hydroxy-3-iodophenyl-4-o-sulfate)-3,5-diiodo-l-tyrosine
3-[4-(4-hydroxy-3-iodophenoxy-4-o-sulfate)-3,5-diiodophenyl]-l-alanine
3,5,3'-triiodo-l-thyronine 4-o-sulphate
triiodothyronine sulphate
3,5,3'-triiodo-l-thyronine 4'-o-sulphate
3-[4-(4-hydroxy-3-iodophenoxy-4-o-sulphate)-3,5-diiodophenyl]-l-alanine
3,5,3'-triiodo-l-thyronine 4-o-sulfate
XBQYQXVJBNDCGY-LBPRGKRZSA-N
3,3 inverted exclamation mark ,5-triiodo-l-thyronine 4 inverted exclamation mark -o-sulfate
Q27116476
(2s)-2-amino-3-[3,5-diiodo-4-(3-iodo-4-sulfooxy-phenoxy)phenyl]propanoic acid
CS-0109171
HY-126996

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response curves of inhibition of binding of [125I]T3S to anti-T3S antibody by serial dilutions of serum extracts were essentially parallel to the standard curve."( A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life.
Chopra, IJ; Santini, F; Teco, GN; Wu, SY, 1992
)
0.54
"0 g/day for 7 days) dosing schedule were employed to achieve varying levels of deiodinase inhibition."( 3,5,3'-Triiodothyronine (T3) sulfate: a major metabolite in T3 metabolism in man.
LoPresti, JS; Nicoloff, JT, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
O-sulfoamino acid
aryl sulfate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (4)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase II - Conjugation of compounds73122
Cytosolic sulfonation of small molecules1747

Bioassays (2)

Assay IDTitleYearJournalArticle
AID681380TP_TRANSPORTER: uptake in Xenopus laevis oocytes1999Biochemical and biophysical research communications, Jan-19, Volume: 254, Issue:2
Identification of thyroid hormone transporters.
AID681333TP_TRANSPORTER: uptake in Xenopus laevis oocytes1999Biochemical and biophysical research communications, Jan-19, Volume: 254, Issue:2
Identification of thyroid hormone transporters.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (31.25)18.7374
1990's21 (65.63)18.2507
2000's0 (0.00)29.6817
2010's1 (3.13)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.00 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.06%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (93.94%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]